Past SARS-CoV-2 infection protection against re-infection: a systematic review and meta-analysis COVID-19 Forecasting Team Summary Background Understanding the level and…
The COVID-NMA initiative A living mapping and living systematic review of Covid-19 trials COVID-NMA is an international research initiative supported…
COVID-19 Living Overview of Evidence repository is highly comprehensive and can be used as a single source for COVID-19 studies…
ROBERTA VILLA DA FNOMCEO: DOTTORE E’ VERO CHE? Guardando i dati globali sull’impatto della pandemia nazione per nazione salta…
How COVID has deepened inequality — in six stark graphics Saima May Sidik The shock waves of the COVID-19 pandemic…
Adapt or die: how the pandemic made the shift from EBM to EBM+ more urgent Trisha Greenhalgh et al. Abstract Evidence-based…
Two new oral antivirals for covid-19: ▼molnupiravir and ▼nirmatrelvir plus ritonavir Abstract This article is made freely available for…
Oral Antiviral Treatments for COVID-19: Molnupiravir and Paxlovid Diana Ernst, RPh Molnupiravir Paxlovid Company Merck Pfizer Generic Name and Formulation…
‘Nocebo effect’: two-thirds of Covid jab reactions not caused by vaccine, study suggests US researchers show negative version of placebo…
RAPID RECOMMENDATIONS A living WHO guideline on drugs for covid-19 Arnav Agarwal et al. https://doi.org/10.1136/bmj.m3379 PER SCARICARE LA GRAFICA INTERATTIVA…
Meta-Analysis of the Effect of Aspirin on Mortality in COVID-19 Husam M. Salah, et al. Repurposing of existing medications has…
Association of mortality and aspirin prescription for COVID-19 patients at the Veterans Health Administration Thomas F. Osborne et al. Abstract…
Molnupiravir for Oral Treatment of Covid-19 in Nonhospitalized Patients Angélica Jayk Bernal et al. BACKGROUND New treatments are needed to…
Why we need to compare the rates of death between vaccinated and unvaccinated During a pandemic, you might see headlines like “Half…
A tale of two antiviral targets — and the COVID-19 drugs that bind them The FDA is considering authorizations for…
How protein-based COVID vaccines could change the pandemic Jabs from Novavax and other biotech firms are coming. Scientists say they…
Serologic response to coronavirus disease 2019 (COVID-19) vaccination in patients with immune-mediated inflammatory diseases: a systematic review and meta-analysis Atsushi…
Molnupiravir vs. COVID-19: Will the drug live up to the hype? Katharine Lang In the search for effective COVID-19 treatments,…
REAL Centre. One year on Three myths about COVID-19 that the data proved wrong Data analysis (PDF version) • 23…
Covid and flu: what do the numbers tell us about morbidity and deaths? Much confusion has been seen in the…
Understanding one in 100,000 What does this tiny probability look like? Anthony B. Masters The EMA stated there was a plausible link…
Is Ivermectin For Covid-19 Based On Fraudulent Research? Part 4 The story of ivermectin for Covid-19 continues to get even…
The pandemic marks another grim milestone: 1 in 500 Americans have died of covid-19 By Dan Keatin , Akilah Johnson and…
Flawed ivermectin preprint highlights challenges of COVID drug studies The study’s withdrawal from a preprint platform deals a blow to…